Forma Therapeutics Holdings Inc (FMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FMTX | AMGN | BMY | GILD | REGN |
| Company | Forma Therapeutics Holdings Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 20.00 | 325.08 | 54.48 | 123.41 | 726.16 |
| High | 20.01 | 326.45 | 54.87 | 123.97 | 729.53 |
| Low | 19.98 | 323.14 | 53.92 | 122.38 | 720.76 |
| Latest | 20.01 | 324.18 | 54.33 | 123.16 | 723.13 |
| Change | +0.03 | -6.23 | -0.93 | -1.75 | -9.91 |
| % Change | +0.15% | -1.89% | -1.68% | -1.40% | -1.35% |
| Volume | 739,100 | 17,054 | 132,505 | 79,700 | 4,341 |
| 20-Day Average Volume | 898,390 | 2,616,568 | 13,460,545 | 6,120,020 | 830,417 |
| Previous Close | 19.98 | 330.41 | 55.26 | 124.91 | 733.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.95 | 329.21 | 54.97 | 123.04 | 771.95 |
| 20-Day Raw Stochastic | 92.86% | 30.92% | 52.61% | 67.33% | 8.74% |
| 20-Day Relative Strength | 84.14 | 49.58 | 56.46 | 52.32 | 46.28 |
| Weighted Alpha | +1.30 | +18.50 | +0.90 | +29.20 | +17.29 |
| Today's Opinion | 100% Buy | 48% Buy | 88% Buy | 72% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 100% Buy | 72% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 72% Buy | 72% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 10/06/22 | +0.11% since 01/12/26 | -1.95% since 01/12/26 | +1.12% since 01/12/26 | -5.01% since 01/12/26 |
| Low | 19.95 on 10/07/22 | 319.79 on 01/13/26 | 53.92 on 01/20/26 | 120.22 on 01/13/26 | 720.76 on 01/20/26 |
| High | 20.01 on 10/13/22 | 333.03 on 01/16/26 | 57.04 on 01/14/26 | 125.12 on 01/16/26 | 766.64 on 01/14/26 |
| 1-Month | |||||
| %Chg | +0.35% since 09/13/22 | -0.46% since 12/19/25 | +0.90% since 12/19/25 | -0.26% since 12/19/25 | -5.00% since 12/19/25 |
| Low | 19.88 on 09/23/22 | 318.21 on 01/05/26 | 52.06 on 01/05/26 | 116.88 on 01/05/26 | 720.76 on 01/20/26 |
| High | 20.08 on 09/15/22 | 343.05 on 01/07/26 | 57.04 on 01/14/26 | 127.41 on 12/23/25 | 821.11 on 01/09/26 |
| 3-Month | |||||
| %Chg | +135.69% since 07/13/22 | +7.44% since 10/20/25 | +25.44% since 10/20/25 | +0.70% since 10/20/25 | +26.49% since 10/20/25 |
| Low | 7.24 on 07/26/22 | 288.00 on 10/31/25 | 42.52 on 10/29/25 | 114.02 on 10/31/25 | 572.75 on 10/23/25 |
| High | 20.28 on 09/01/22 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| 6-Month | |||||
| %Chg | +128.42% since 04/13/22 | +10.56% since 07/18/25 | +15.46% since 07/18/25 | +14.55% since 07/18/25 | +34.47% since 07/18/25 |
| Low | 4.95 on 06/16/22 | 269.77 on 09/26/25 | 42.52 on 10/29/25 | 107.75 on 07/21/25 | 541.00 on 10/13/25 |
| High | 20.28 on 09/01/22 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 957,539 | 177,919,520 | 112,495,712 | 154,973,344 | 77,041,760 |
| Shares Outstanding, K | 47,853 | 538,481 | 2,035,753 | 1,240,680 | 105,099 |
| Annual Sales | 0 | 33,424,000,000 | 48,300,000,000 | 28,754,000,000 | 14,202,000,000 |
| Annual Net Income | -172,960,000 | 4,090,000,000 | -8,948,000,000 | 480,000,000 | 4,412,600,000 |
| Last Quarter Sales | 0 | 9,557,000,000 | 12,222,000,000 | 7,769,000,000 | 3,754,300,000 |
| Last Quarter Net Income | -52,578,000 | 3,216,000,000 | 2,201,000,000 | 3,052,000,000 | 1,460,000,000 |
| 60-Month Beta | -0.94 | 0.45 | 0.29 | 0.33 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 08/05/22 | 5.64 on 11/04/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 | 11.83 on 10/28/25 |
| Latest Earnings Date | 11/11/22 | 02/03/26 | 02/05/26 | 02/10/26 | 01/30/26 |
| Most Recent Dividend | N/A | 2.380 on 11/21/25 | 0.630 on 01/02/26 | 0.790 on 12/15/25 | 0.880 on 11/20/25 |
| Next Ex-Dividends Date | N/A | 02/13/26 | 01/02/26 | 12/15/25 | 11/20/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.09 | 8.63 | 14.81 | 20.23 |